3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Digital Asset Acquisition Corp. (DAAQ), a special purpose acquisition company, entered into a merger agreement on October 7, 2026 with Titan Strategics Holdings Ltd, whose subsidiary holds exploration permits for the Billingen Project in Sweden. The combined company is to be renamed Renaissance Nuclear, Inc. and the deal requires shareholder and regulatory approvals, with completion expected in early 2027. For DAAQ shareholders, the deal would issue 25,000,000 shares to Titan's equity holders and dilute existing holders, while the filing states that the historical uranium results have not yet been verified by a Qualified Person.
Base purchase price of $250,000,000, equal to 25,000,000 Parent Common Shares at $10.00 per share.
Titan's existing equity holders are expected to own about 70% of the combined company, excluding warrants, equity plan shares and any redemptions.
Expected gross transaction proceeds of about $65 million, including a minimum of $15 million PIPE investment.
Closing requires at least $10,000,000 of Parent Closing Cash and shareholder approval; completion is expected in early 2027.
On October 7, 2026, X4 Pharmaceuticals and its subsidiary X4 Therapeutics entered a Loan and Security Agreement with K2 HealthVentures providing term loans of up to $150.0 million. An $80.0 million first tranche funded at closing and was used to repay in full the Hercules loan, with a total payoff of approximately $78.7 million. For shareholders, the deal refinances existing debt and adds up to $70.0 million of possible further borrowing, but it carries variable-rate interest, secured liens, financial covenants, and a conversion feature that could issue common stock.
First tranche of $80.0 million funded October 7, 2026; up to $70.0 million more available at the company's request, subject to lender review and discretionary approval.
Hercules payoff of approximately $78.7 million, including $75.0 million of principal, ended the prior Hercules Loan Agreement and released its liens.
Cash interest is the greater of 8.55% or the WSJ prime rate plus 1.55%, plus 1.0% paid-in-kind interest; interest-only through October 1, 2029; maturity October 1, 2030.
Lenders may convert up to $15.0 million of principal into common stock at $3.2341 per share; minimum cash covenant applies from October 1, 2027 when market capitalization is below $800.0 million.
Hess Midstream LP and its subsidiary signed an agreement on October 6, 2026 to acquire Chevron's DJ Basin crude oil and gas gathering and storage assets and to take over Chevron's ownership interests in the partnership and its general partner. The company will pay $200 million in cash plus closing working capital, and the filing says the partnership's outstanding shares are expected to fall by nearly 40% at closing. Bakken commercial agreements with Chevron will be amended to reduce tariffs and extend terms through 2045, and the company updated its 2026 guidance.
Partnership to pay Chevron-affiliated sellers $200 million in cash plus closing working capital of CMH, with a post-closing adjustment
Chevron to contribute its consolidated ownership interests in Hess Midstream, with outstanding shares expected to decrease by nearly 40% at closing
Bakken agreements amended to reduce tariffs for Chevron, with terms extended to December 31, 2045 and a minimum revenue commitment of 80% through December 31, 2033
2026 guidance updated to net income of $650 million to $675 million and Adjusted EBITDA of $1,225 million to $1,250 million; closing expected by year-end 2026
Twin Vee PowerCats and USFM Corporation signed an amended and restated merger agreement dated October 7, 2026, which replaces the July 12, 2026 agreement. Under the amended terms, pre-closing Twin Vee stockholders would own 7% of the combined company's shares, down from 10% under the original deal, and would receive contingent value rights in a trust that would hold Twin Vee's marine business.
Amended agreement dated October 7, 2026 replaces the merger agreement first signed on July 12, 2026.
Pre-closing Twin Vee stockholders would hold 7% of Pubco shares, down from 10% under the original agreement.
Termination fees are $500,000 payable by USFM and $800,000 payable by Twin Vee in specified circumstances.
Closing is expected in the fourth quarter of 2026 or the first quarter of 2027, subject to Twin Vee stockholder approval and other conditions.
GEO Group delivered a notice to redeem all $650.0 million of its 8.625% Senior Secured Notes due 2029, at about $678 million plus accrued interest, on October 15, 2026. The company said it will fund the redemption with net proceeds from recently announced asset sales. A new credit agreement extends the $550.0 million revolving facility to July 14, 2031 and allows unlimited share repurchases if the total leverage ratio is 2.25 to 1.00 or lower, which matters to shareholders because it expands the company's capacity to buy back stock.
Redemption of $650.0 million 2029 Senior Secured Notes at $1,043.13 per $1,000 principal, about $678 million, on October 15, 2026
Amended and Restated Credit Agreement closed October 5, 2026; $550.0 million revolver maturity extended to July 14, 2031
Share repurchases permitted without limit if pro forma total leverage ratio is 2.25 to 1.00 or lower and no default exists
Board approved a $750 million increase in the share repurchase program, from $500 million to $1.25 billion, effective through December 31, 2029
Lifeward Ltd. said on October 4, 2026 that Rami Aviram, whom it had appointed as Chief Financial Officer effective November 1, 2026, has decided not to join and will not take the role. Josh Hexter will continue as interim principal financial officer and principal accounting officer until a successor is appointed, and the company is searching for a permanent CFO. The change leaves the finance leadership role unfilled and without a set date for a successor.
Rami Aviram informed the company on October 4, 2026 that he will not join as CFO, which was originally set for November 1, 2026.
Josh Hexter remains interim principal financial officer and principal accounting officer, with no additional compensation for these duties.
The company is conducting a search for a permanent CFO and will announce a successor when the search concludes.
MFA Financial announced that CEO Craig Knutson will retire effective June 30, 2027, and that President and Chief Investment Officer Bryan Wulfsohn will succeed him as CEO effective July 1, 2027. Wulfsohn will join the Board effective January 1, 2027, and Andrew Kail will join as Chief Investment Officer on the same date, giving shareholders a defined leadership transition timeline.
Craig Knutson, 67, retires as CEO effective June 30, 2027, and is expected to remain on the Board and stand for reelection in 2027
Bryan Wulfsohn, 43, becomes CEO effective July 1, 2027, and joins the Board effective January 1, 2027, increasing the Board to eight directors
Andrew P. Kail joins as Senior Vice President and Chief Investment Officer effective January 1, 2027
Wulfsohn's 2027 Overall Target Bonus is $1,700,000 and his 2027 TRSU and PRSU grant values are $1,160,000 and $1,740,000; Knutson's 2027 equity grants are cut 50% to $843,000 (TRSUs) and $1,264,500 (PRSUs)
EOG Resources said on October 8, 2026 that it now expects third quarter 2026 current tax expense of $835 million to $935 million, up from its August 4, 2026 forecast of $545 million to $645 million. The company attributed the increase to higher crude oil prices realized in the third quarter and expected for the full year amid the ongoing Middle East conflict. EOG said it is not updating any other third quarter or full year 2026 guidance from August.
Current tax expense guidance for Q3 2026 raised to $835 million-$935 million from $545 million-$645 million set on August 4, 2026
Increase reflects higher crude oil prices realized in Q3 2026 and anticipated for the full year due to the ongoing Middle East conflict
Q3 2026 NYMEX WTI crude averaged $85.68 per barrel; EOG received net cash of $40 million from financial commodity derivative settlements
All other third quarter and full year 2026 guidance from August 4, 2026 was not updated
Tenax Therapeutics temporarily paused enrollment in its LEVEL-2 Phase 3 trial of TNX-103 while it amends the enrollment criteria to target patients with lower baseline 6-minute walk distance, based on results from the LEVEL trial. The company also said it has requested a Type C meeting with the U.S. Food and Drug Administration to discuss the overall development of levosimendan. The pause delays enrollment in a pivotal trial, and the company's investor presentation states that the LEVEL trial did not meet its primary endpoint in the overall population.
Enrollment in LEVEL-2 is paused and may resume at each site as the amended protocol takes effect there.
The amendment targets patients with baseline 6-minute walk distance of 100m to 300m, or above 300m to 400m with a right atrial volume index of 25 mL/m2 or more.
The LEVEL trial's overall primary endpoint difference was 3.5 M (p = 0.63), according to the investor presentation attached as Exhibit 99.1, dated October 8, 2026.
On October 5, 2026, the Audit Committee dismissed WithumSmith+Brown as Elauwit Connection's independent auditor, effective immediately, and engaged MPB Global LLP for the fiscal year ending December 31, 2026. The filing says WithumSmith+Brown issued no report after March 31, 2026 on the 2025 financial statements, and it cites material weaknesses in internal control over financial reporting disclosed in the company's 2025 Form 10-K. Shareholders may want to watch for the new auditor's work and any further disclosure about those weaknesses.
Audit Committee approved the dismissal of WithumSmith+Brown on October 5, 2026, effective immediately.
WithumSmith+Brown was engaged August 26, 2025, and did not issue a report after March 31, 2026 on the 2025 financial statements.
Its 2025 audit report had no adverse opinion or disclaimer and was not qualified or modified.
MPB Global LLP was engaged on October 5, 2026, as the new auditor for fiscal 2026; the filing cites material weaknesses in internal control from the 2025 Form 10-K.
AGNT, Inc. said its founder and Chief Executive Officer, Glenn Sanford, will step down as CEO effective October 8, 2026, and remain Chairman of the Board. The Board unanimously appointed Leo Pareja, CEO of eXp Realty since April 2024, as CEO effective the same date, and he signed an employment agreement with a five-year initial term. Shareholders should note the new CEO's pay package, including a base salary increase to $1,800,000 and a promotional equity grant.
Leo Pareja becomes CEO effective October 8, 2026; the Board approved the appointment on October 6, 2026.
Pareja's annual base salary rises to $1,800,000 under the Employment Agreement.
Promotional grant includes a stock option covering 1,060,814 shares at target, with vesting of 0% to 200% based on relative total shareholder return, and 573,588 restricted stock units.
The 2027 annual equity award has a grant-date value of $4,897,500; Sanford will receive the standard non-employee director compensation package as Chairman.
SEGG said sworn deposition testimony and a later internal inquiry showed that 2020 and 2021 transactions tied to its former Lottery.com and AutoLotto management were circular and overstated revenue and the Global Gaming acquisition cost. The company will correct its 2023, 2024 and 2025 annual and quarterly financials, which reduces previously reported losses and goodwill, and says its 2021 and 2022 reports should no longer be relied upon.
A $9,000,000 transaction with Datassure was recorded as revenue and cash in December 2020; the Global Gaming acquisition cost was overstated to $10,572,674 in June 2021.
Restated 2023 net loss attributable to SEGG is $(22,652,139), down from $(25,563,699) as previously reported; restated 2024 is $(24,749,831), down from $(28,221,605).
Restated 2025 net loss attributable to SEGG is $(19,687,362), compared with $(20,303,608) previously reported.
Former CEO Vadim Komissarov was sentenced to three years in prison on June 24, 2026; two former executives pleaded guilty on May 22, 2025 and await sentencing.
Pacira BioSciences agreed to be acquired by Viatris through a cash tender offer at $36.50 per share, followed by a second-step merger, for an aggregate equity value of $1.65 billion. Pacira's board unanimously recommends that shareholders tender their shares, and the deal is expected to close by the end of 2026, subject to a majority tender and regulatory clearance.
Cash offer of $36.50 per share, with a $1.65 billion aggregate equity value
Tender offer to start within 15 business days of the October 8, 2026 agreement; deal expected to close by end of 2026
Pacira would pay Viatris a $62.0 million termination fee if it accepts a superior offer
Pacira generated approximately $746 million in revenue and $177 million in adjusted EBITDA in the twelve months ended June 30, 2026
Charlton Aria Acquisition Corp furnished an investor presentation and script for its proposed business combination with KQC Quantum, Inc., which was agreed on October 6, 2026. A joint webcast is scheduled for 10:30 a.m. Eastern Time on October 8, 2026. The deck shows a $80.0 million pre-money equity valuation and a trust balance of about $93.5 million before redemptions, so the amount of cash available at closing will depend on shareholder redemptions.
Pre-money KQC Parent equity valuation of $80.0 million; minimum cash condition of $30.0 million
Trust held about $93.5 million at September 25, 2026, or $11.00 per public share, before redemptions
Maximum redemption consistent with the minimum cash condition is about 68% of public shares; target closing in H1 CY27
Joint investor webcast at 10:30 a.m. Eastern Time on Thursday, October 8, 2026
RB Global appointed Steve Steinberg as Chief Financial Officer effective October 7, 2026, replacing Eric Guerin, whose last day was October 6, 2026. The company also said it expects full-year 2026 results to be at the high end of its August 4, 2026 outlook, which is a signal on performance for shareholders.
Steve Steinberg, 62, becomes CFO effective October 7, 2026, with an annual base salary of $625,000 and a target bonus of 100% of salary
Eric Guerin's last day as CFO was October 6, 2026; COO Steve Lewis's last day is expected to be October 9, 2026
2026 results expected at the high end of the August 4, 2026 outlook: GTV growth of 9-11% and Adjusted EBITDA of $1,495 million to $1,545 million
Third quarter 2026 results are scheduled for release before market open on November 9, 2026
Hallador Energy's subsidiary Hallador Power signed a six-year power purchase agreement and a capacity credit sale agreement with Duke Energy Indiana, both covering output from the Merom Generating Station from June 1, 2029 through May 31, 2035. The filing says Duke Energy Indiana will pay approximately $271 million for the capacity credits over the term, and the company's press release puts total forward sales at $3 billion. The deals lock in future revenue for much of Merom's output but require standby letters of credit and are unit contingent.
Capacity agreement: 225 ZRCs per day on average, with Duke Energy Indiana paying approximately $271 million over the six-year term
Energy agreement: 200 MW annual average base energy quantity, unit contingent, with the company estimating about $422 million of energy revenue at current forward prices
Standby letters of credit: $3.5 million for the PPA rising to $7.0 million in January 2029, and $6 million for the MPPSA rising to $12 million in January 2029
Press release says the agreements raise total forward sales to $3 billion; full agreements to be filed with the next Form 10-Q
Viatris signed a merger agreement on October 8, 2026 to acquire Pacira BioSciences through a cash tender offer at $36.50 per share, an aggregate equity value of $1.65 billion. Viatris said it expects to fund the deal primarily from excess cash, with the rest from short-term borrowings, and expects it to be immediately accretive to its financial guidance metrics and to close by the end of 2026. The deal is a large acquisition that would add Pacira's marketed EXPAREL and ZILRETTA products to Viatris.
Offer price of $36.50 per share in cash; aggregate equity value of $1.65 billion per the joint press release.
Pacira generated approximately $746 million in total revenue and $177 million in adjusted EBITDA for the twelve months ended June 30, 2026.
Completion requires a majority of Pacira shares tendered; the offer is open for 10 business days, and the merger agreement's outside date is April 8, 2027.
Pacira would pay Viatris a $62 million termination fee under specified circumstances, including a Superior Offer.
Byrna Technologies reported fiscal third-quarter 2026 results for the period ended August 31, 2026. Net revenue fell about 46% from a year earlier and the company posted a net loss of $2.9 million, compared with net income of $2.2 million in the prior-year quarter, with management citing lower e-commerce sales and slower dealer and chain-store reorders.
Net revenue was $15.3 million, versus $28.2 million in Q3 2025.
Net loss was $2.9 million, or $0.13 per diluted share, versus net income of $2.2 million, or $0.09 per diluted share, a year earlier.
Gross margin reached 79%, but included a one-time $2.3 million tariff refund; excluding it, adjusted gross margin was about 65%, compared with 60% a year earlier.
Cash, cash equivalents and marketable securities were $9.4 million at August 31, 2026, and inventory was $30.0 million.
NOVAGOLD reported a net loss of $36.0 million, or ($0.08) per share, for the quarter ended August 31, 2026, a period in which it had no production. It raised its fiscal 2026 operating expenditure guidance by $11.5 million to approximately $110.0 million, citing legal and professional fees tied to its pending all-share deal to acquire Paulson's 40% interest in Donlin Gold, which would give it 100% ownership. That deal is expected to close by year-end, subject to shareholder approval at a special meeting on November 3, 2026.
Q3 ended August 31, 2026: net loss of $36.0 million and EPS of ($0.08); the company is development-stage with no production.
Fiscal 2026 operating expenditure guidance raised $11.5 million to approximately $110.0 million; Donlin Gold funding guidance unchanged at approximately $78.8 million.
Cash and term deposits were $343.4 million as of August 31, 2026, down from $370.2 million as of May 31, 2026.
Paulson 40% Donlin Gold stake acquisition expected to close in the fourth calendar quarter of 2026; special shareholder meeting set for November 3, 2026.
AngioDynamics reported fiscal first-quarter 2027 net sales of $80.9 million, up 6.9%, and a GAAP net loss of $7.1 million, or $0.17 per share, versus a loss of $10.9 million a year earlier. The company also said Eric Honroth will succeed Jim Clemmer as President and CEO on November 2, 2026, and reiterated its fiscal 2027 guidance, which matters to shareholders because it signals continuity in results and a planned leadership change.
Net sales were $80.9 million, up 6.9%; Med Tech sales rose 13.2% to $39.9 million while Med Device sales rose 1.4% to $41.0 million.
GAAP net loss narrowed to $7.1 million, or $0.17 per share, from $10.9 million, or $0.26 per share, a year earlier.
Adjusted EBITDA was $5.0 million versus $2.2 million; gross margin was 59.4%, including $1.2 million of tariff refunds.
Eric Honroth becomes CEO effective November 2, 2026, succeeding Jim Clemmer; fiscal 2027 net sales guidance of $336.0 million to $341.0 million was reiterated.
AngioDynamics said Eric Honroth will become President and Chief Executive Officer and a director effective November 2, 2026, succeeding James Clemmer, who has led the company since April 2016 and is retiring. The filing also sets Honroth's pay, including a $735,000 base salary and a $350,000 sign-on bonus, and a $30,000 monthly consulting arrangement for Clemmer for one year.
Eric Honroth, 55, most recently served as President Life Science at Getinge AB from 2018 to 2026.
Honroth's base salary is $735,000, with a target annual bonus of 95% of base salary.
Honroth receives a $350,000 cash sign-on bonus, repayable if he leaves without Good Reason or is terminated for Cause within the first year.
Clemmer will consult for the company for one year at $30,000 per month; Howard Donnelly plans to retire as a Class II director at the end of his current term.
Crescent Energy agreed on October 8, 2026 to acquire certain Eagle Ford assets from a Devon Energy subsidiary for $4.22 billion in cash, subject to customary purchase price adjustments, with closing expected in the fourth quarter of 2026 or early 2027. The company obtained a JPMorgan Chase debt commitment for a bridge credit facility of up to $2.0 billion and plans to fund the deal with cash on hand and, as appropriate, a mix of debt and equity. The filing's pro forma figures show 2025 results moving from $167.2 million of net income to a $373.6 million net loss after giving effect to the transactions and related financing.
Purchase price of $4,220,000,000 in cash, with reductions for hydrocarbon sales proceeds after the July 1, 2026 economic effective date
Bridge credit facility of up to $2.0 billion from JPMorgan Chase Bank, N.A., subject to customary terms and conditions
Expected closing in the fourth quarter of 2026 or early 2027; press release cites an estimated net purchase price of about $3.85 billion
Acquired assets produced about 68 MBoe/d in July 2026; pro forma 2026 capital expenditures estimated at about $1.75 billion
Henry Schein said former ITT CFO Emmanuel Caprais will become its Senior Vice President and Chief Financial Officer effective November 4, 2026, succeeding Ronald N. South, who moves to a Senior Advisor role on that date. Mr. Caprais joins as Senior Financial Advisor on October 12, 2026, and Mr. South remains CFO through November 3, 2026, including the third quarter earnings process. The filing describes a planned, structured handover of the finance chief role rather than a financial result.
Emmanuel Caprais, 51, most recently served as CFO of ITT Inc. from 2020 to May 2026; he will report to CEO Frederick M. Lowery
Offer Letter sets a $750,000 base salary, a $750,000 target annual bonus, and a $25,000 sign-on bonus
Expected 2027 long-term incentive award has an estimated grant date fair value of $2,500,000, plus a $250,000 one-time sign-on equity award granted in December 2026
Ronald N. South has served at Henry Schein for 18 years and as CFO for the past four years
An ICC arbitration tribunal ruled 2-1 in a partial final award that Venture Global's VGCP unit breached its obligation to timely declare commercial operation of the Calcasieu Project under its SPA with Galp. Remedies will be set in a damages hearing not yet scheduled, expected in 2027 or 2028, and the final award will be capped at $170 million, which the company says does not change ongoing deliveries.
Tribunal found VGCP breached its obligation to declare COD on time; one of three arbitrators dissented.
Final award expected after a damages hearing anticipated in 2027 or 2028; final award subject to a $170 million seller aggregate liability cap.
Company says it is disappointed, is evaluating all options, and notes 20 cargos delivered to Galp since COD on April 15, 2025.
Helen of Troy reported second-quarter fiscal 2027 net sales of $440.9 million, up 2.1% from $431.8 million, and GAAP diluted EPS of $0.19, compared with a loss of $13.44 a year earlier that included asset impairment charges. The company raised its fiscal 2027 GAAP diluted EPS outlook to $3.63-$4.26 and its adjusted diluted EPS outlook to $3.60-$4.15, which gives shareholders a higher expected profit range, though the filing notes the outlook includes tariff refunds that the company plans to partly reinvest.
Q2 net sales of $440.9 million, up 2.1%; GAAP diluted EPS of $0.19 versus a $13.44 loss a year earlier
Adjusted diluted EPS of $0.79, compared with $0.59; the quarter includes a net pre-tax tariff refund benefit of about $4.0 million
Fiscal 2027 consolidated net sales outlook narrowed to $1.768-$1.822 billion; GAAP diluted EPS outlook raised to $3.63-$4.26
Free cash flow outlook raised to $120-$140 million; the company plans to reinvest the vast majority of tariff refunds
Subsidiaries TCDC PowerCo and Texas Critical Data Centers entered into a Letter of Credit Reimbursement Agreement with Macquarie Bank on October 7, 2026, to back a $116.0 million standby letter of credit for a power purchase agreement with Luminant. The arrangement carries 12% annual interest on reimbursements and required cash collateral, and the company issued warrants to the lender, which would add potential dilution for shareholders.
$116.0 million standby letter of credit issued in favor of Luminant ET Services to secure PowerCo's obligations under the power purchase agreement
PowerCo must reimburse the Bank at 12% per annum; TCDC has unconditionally guaranteed these obligations
Cash collateral must be kept at not less than 102% of the undrawn face amount (approximately $118.3 million at issuance), with $60.0 million funded from Term Loan A-2 and A-3 proceeds and about $58.3 million from cash on hand
Warrants issued to the lender for 413,055 shares of common stock at an exercise price of approximately $7.26; the company also began pursuing direct leases with hyperscale tenants for the TCDC Project
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.